ECSCs_a |
Endometrioid carcinoma of the corpus uteri |
GII |
female |
72 |
ECSCs_b |
Endometrioid carcinoma of the corpus uteri |
GI |
female |
83 |
ECSCs_c |
Endometrioid carcinoma of the corpus uteri with invasion of the outer half of the myometrium and invasion of the cervix uteri |
GII |
female |
86 |
GSCs_a |
Primary glioblastoma multiforme, IDH1 wildtype with MGMT promoter methylation |
GIV |
female |
60 |
GSCs_b |
Secondary glioblastoma multiforme, IDH1 mutation with MGMT promoter methylation |
GIV |
male |
42 |
GSCs_c |
Primary glioblastoma multiforme, IDH1 wildtype without MGMT promoter methylation |
GIV |
male |
69 |
LCSCs_a |
Highly metastatic adenocarcinoma of the lung, EGFR mutation |
n.a. |
female |
50 |
LCSCs_b |
Multifocal adenocarcinoma of the lung |
GII |
female |
61 |
LCSCs_c |
Adenocarcinoma of the lung, KRAS and STK11 mutation |
GII |
female |
49 |
PCSCs_a |
Acinar adenocarcinoma |
GIII |
male |
71 |
PCSCs_b |
Acinar adenocarcinoma |
GII |
male |
57 |
PCSCs_c |
Locally advanced acinar adenocarcinoma |
GV |
male |
72 |